MAKO Surgical Corp., a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced that it closed its public offering of 3,498,300 shares of its common stock, which includes 456,300 shares issued as a result of the underwriter's exercise of their over-allotment option.
MAKO Surgical Corp. closes public offering of common stock